Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency? A comparison with noninvasive exocrine pancreatic function tests

Journal of Clinical Gastroenterology

Volumn 40, Issue 9, 2006, Pages 851-855

  Schneider, Arne R J ^a   Hammerstingl, Renate ^a   Heller, Matthias ^a   Povse, Nada ^a   Murzynski, Lydia ^a   Vogl, Thomas J ^a   Caspary, Wolfgang F ^a   Stein, Juergen ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Chronic pancreatitis; Exocrine pancreatic insufficiency; MRCP; Secretin

Indexed keywords

ELASTASE; FECES LIPID; SECRETIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DUODENUM; FECES; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MORPHOLOGY; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION TEST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PANCREATIC FUNCTION TESTS; PANCREATITIS, CHRONIC; SECRETIN;

EID: 33749406385     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225652.00308.a2     Document Type: Article

References (28)

1. Siegmund E, Loehr JM, Schuff-Werner P. The diagnostic validity of non-invasive pancreatic function tests-a meta-analysis. Z Gastroenterol. 2004;42:1117-1128.
2. Stein J, Jung M, Sziegoleit A, et al. Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem. 1996;42:222-226.
3. Stein J, Spichez Z, Lembcke B, et al. Evaluation of fecal elastase as a new non-invasive test for exocrine pancreatic insufficiency. Z Gastroenterol. 1997;(suppl. 1):122-129.
4. Chowdhury RS, Forsmark CE. Review article: pancreatic function testing. Aliment Pharmacol Ther. 2003;17:733-750.
5. Clain JE, Pearson RK. Diagnosis of chronic pancreatitis. Is a gold standard necessary? Surg Clin North Am. 1999;79:829-845.
6. Roberts IM, Poturich C, Wald A. Utility of fecal fat concentrations as screening test in pancreatic insufficiency. Dig Dis Sci. 1986;31:1021-1024.
7. Dumasy V, Delhaye M, Cotton F, et al. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol. 2004;99:1350-1354.
8. Loser C, Brauer C, Aygen S, et al. Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol. 1998;33:327-334.
9. Ventrucci M, Cipolla A, Ubalducci GM, et al. 13C labeled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut. 1998;42:81-87.
10. Hellerhoff KJ, Heimberger H 3rd, Roesch T, et al. Dynamic MR pancreatography after secretion administration: image quality and diagnostic accuracy. Am J Roentgenol. 2002;179:121-129.
11. Fukukura Y, Fujiyoshi F, Sasaki M, et al. Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology. 2002;222:674-680.
12. Heverhagen JT, Battmann A, Kirsch M, et al. Magnetic resonance hydrometry: non-invasive quantification of the exocrine pancreatic function. Rofo. 2002;174:291-296.
13. Nanashima A, Yamaguchi H, Fukuda T, et al. Evaluation of pancreatic secretion after administration of secretin: application of magnetic resonance imaging. J Gastroenterol Hepatol. 2001;16:87-92.
14. Czako L, Endes J, Takacs T, et al. Evaluation of pancreatic exocrine function by secretin-enhanced magnetic resonance cholangiopancreatography. Pancreas. 2001;23:323-328.
15. Cappeliez O, Delhaye M, Deviere J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology. 2000;215:358-364.
16. Monill J, Pernas J, Clavero J, et al. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography. Am J Roentgenol. 2004;183:1267-1274.
17. Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25:1107-1112.
18. Stein J, Purschian B, Zeuzem S, et al. Quantification of fecal carbohydrates by near-infrared reflectance analysis. Clin Chem. 1996;42:309-312.
19. Adamek HE, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet. 2000;356:190-193.
20. Calvo MM, Bujanda L, Calderon A, et al. Comparison between magnetic resonance cholangiopancreatography and ERCP for evaluation of the pancreatic duct. Am J Gastroenterol. 2002;97:347-353.
21. Ly IN, Miller FH. MR imaging of the pancreas: a practical approach. Radiol Clin North Am. 2002;40:1289-1306.
22. Gunkel U, Bitterlich N, Keirn V. Value of combinations of pancreatic function tests to predict mild or moderate chronic pancreatitis. Z Gastroenterol. 2001;39:207-211.
23. Lankisch PG. Function tests in the diagnosis of chronic pancreatitis. Critical evaluation. Int J Pancreatol. 1993;14:9-20.
24. Lankisch PG, Andren-Sandberg A. Standards for the diagnosis of chronic pancreatitis and for the evaluation of treatment. Int J Pancreatol. 1993;14:205-212.
25. Renou C, Grandval P, Ville E, et al. Endoscopic treatment of the main pancreatic duct: correlations among morphology, manometry and clinical follow-up. Int J Pancreatol. 2000;27:143-149.
26. Ponchon T, Bory RM, Hedelius F, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc. 1995;42:452-456.
27. Abou-Rebyeh H, Koehler U, Paetsch I, et al. MRCP-gestuetzte Flur1messungen am bilio-pankreatischen Gangsystem. Z Gastroenterol. 2004;42:897.
28. Bali MA, Sztantics A, Metens T, et al. Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance choalgiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results. Eur Radiol. 2005;15:2110-2121.